| Marvin R Keeling, MD | |
|
1484 Straits Dr Ste 5, Bay City, MI 48706-8718 | |
| (989) 667-8740 | |
| (989) 667-8745 |
| Full Name | Marvin R Keeling |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1484 Straits Dr Ste 5, Bay City, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023030772 | NPI | - | NPPES |
| P00458078 | Other | MI | RAILROAD MEDICARE |
| 045279 | Other | MI | STATE LICENSE |
| 5221962 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MK045279 (Michigan) | Primary |
| Entity Name | Michigan Healthcare Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275858862 PECOS PAC ID: 2466626270 Enrollment ID: O20111114000025 |
News Archive
A common antibiotic can help reduce the severe wheezing and other acute symptoms of chronic obstructive pulmonary disease, according to a large, multicenter clinical trial sponsored by the National Institutes of Health and conducted at the University of California, San Francisco (UCSF).
Research conducted at the Oregon National Primate Research Center reveals that an individual's activity level is the most constant factor in predicting weight gain over adulthood.
Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. Food and Drug Administration, according to a City of Hope-led study.
Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-closing merger-related expenses. Third-quarter GAAP EPS was $1.61.
A new report, 'No Second Chances', developed by the Baker Heart and Diabetes Institute and sponsored by Bayer, will be launched at Parliament House today, revealing that prevention of secondary heart attacks and strokes is critical to combating Australia's number one killer - cardiovascular disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marvin R Keeling, MD Po Box 126, Deckerville, MI 48427-0126 Ph: (810) 376-3100 | Marvin R Keeling, MD 1484 Straits Dr Ste 5, Bay City, MI 48706-8718 Ph: (989) 667-8740 |
News Archive
A common antibiotic can help reduce the severe wheezing and other acute symptoms of chronic obstructive pulmonary disease, according to a large, multicenter clinical trial sponsored by the National Institutes of Health and conducted at the University of California, San Francisco (UCSF).
Research conducted at the Oregon National Primate Research Center reveals that an individual's activity level is the most constant factor in predicting weight gain over adulthood.
Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. Food and Drug Administration, according to a City of Hope-led study.
Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-closing merger-related expenses. Third-quarter GAAP EPS was $1.61.
A new report, 'No Second Chances', developed by the Baker Heart and Diabetes Institute and sponsored by Bayer, will be launched at Parliament House today, revealing that prevention of secondary heart attacks and strokes is critical to combating Australia's number one killer - cardiovascular disease.
› Verified 8 days ago
John A Howland, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2110 16th St, Bay City, MI 48708 Phone: 989-892-1231 Fax: 989-892-1881 | |
Krisshonda D Mckinney, FNP-C Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3720 Katalin Ct, Bay City, MI 48706 Phone: 989-686-2800 | |
Dr. Algimantas P Maciulis, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 S. Wenona St, Suite 260, Bay City, MI 48706 Phone: 989-894-6040 Fax: 989-892-3983 | |
Dr. Lakshmi Arekapudi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3720 Katalin Ct, Bay City, MI 48706 Phone: 989-686-2800 | |
Ali Soueidan, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 S Trumbull St, Bay City, MI 48708 Phone: 989-893-7460 Fax: 989-895-5813 | |
Dr. Praveen Kumar Kamaraju, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3720 Katalin Court, Bay City, MI 48706 Phone: 989-686-2800 Fax: 989-686-5920 |